IP Update: Recent Patents, Patent Applications Awarded to Alnylam, CSIRO, Cerulean, and More | GenomeWeb

Title: Treating Picornavirus Infection by Targeting microRNA miR-141

Patent Number: 8,263,570

Filed: Dec. 15, 2009

Lead Inventor: Bing-Ching Ho, National Taiwan University

The invention, the patent's abstract states, involves treating “picornavirus infection by inhibiting miR-141 activity. Also disclosed herein are a method for [identifying] miR-141 inhibitory compounds and a method for identifying a target viral infection to be treated by anti-miR-141 therapy.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.